Skip to main content

Crohn’s Disease Diagnosis

How is Crohn’s disease diagnosed?

Crohn’s disease is suspected in people who have been experiencing symptoms such as chronic abdominal pain, diarrhoea, and weight loss. Symptoms that lasts for weeks or months are key areas for suspicion of Crohn’s disease. As the Crohn’s disease can mimic the similar conditions, and has no single conclusive test to establish its diagnosis, it can take time to correct arrive at this diagnosis. The medical investigation will include a series of Crohn’s disease specific tests to come to a conclusion:

  • Complete personal medical history, including full review of all symptoms
  • Complete family history
  • Physical examination
  • Examination of stool samples to rule out infectious diseases or check for blood in the stool
  • Complete blood count (CBC) or full blood count (FBC), which can provide additional clues to one’s overall health. For example, low levels of red blood cells can suggest internal bleeding and the presence of anaemia. A high white blood cell count, a higher-than-normal level of C-reactive protein (CRP), or a high erythrocyte sedimentation rate (ESR) can indicate the presence of inflammation somewhere in the body.
  • Internal investigations, including:
  • Taking of barium sulphate suspension, followed by x-rays to show areas of inflammation in the stomach and the small intestine
  • Barium enema (if the disease is suspected lower down the GI tract) followed by x-rays to show areas of inflammation in the colon and rectum
  • Endoscopy, to determine the extent and severity of disease. Depending on the suspected location of the inflammation, there are a number of different endoscopy procedures that will be performed, including:
    • sigmoidoscopy if examination is limited to the rectum and sigmoid colon
    • colonoscopy if the entire colon is viewed
    • ileocolonoscopy if the colon and distal ileum are viewed
    • enteroscopy if the small bowel is viewed
    • gastroscopy if the stomach and upper duodenum are viewed.

During these procedures, a biopsy (examining a small sample of tissue under a microscope) might be done. The characteristic pattern of Crohn’s disease under microscopic examination can distinguish it from other diseases of the colon, such as ulcerative colitis or colorectal cancer.

Other types of investigations that are helpful in diagnosing Crohn’s disease are computed tomography (CT) scanning, magnetic resonance imaging (MRI), and ultrasound. All of these investigations give the medical team a look inside the body without the need for invasive procedures such as the insertion of a needle or instrument. Your clinical team will advise you if any of these procedures is right for you.

Additional Information:

The latest news and Research

News

Gutsy effort to produce comprehensive study of intestinal gases

Posted: September 18 2019

A source of embarrassment to some, or pure comedy to others, flatulence and the gases of the intestines are increasingly seen as playing an important role in our digestive health. A paper led by UNSW Sydney and published in Nature Reviews Gastroenterology & Hepatology has examined all available literature on gastrointestinal gases, their interactions with the microbiome […]

Read more

News

Putting an end to inflammation

Posted: September 18 2019

Physician Dr. Andreas Ramming from Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) has succeeded in securing research funding in one of the toughest European selection processes. Over the next five years, the European Research Council (ERC) will support his outstanding research project with an ERC Starting Grant of 1.5 million euros. Dr. Andreas Ramming from the Department of Medicine […]

Read more

Research

Scientists discover promising new lead in Crohn’s disease

QIMR Berghofer researchers have identified a key driver of the aggressive gut disorder, Crohn’s disease, a finding that could eventually lead to new treatments for the often-debilitating condition.

Crohn’s disease – also known as inflammatory bowel disease – is incurable and affects about 35,000 people in Australia. QIMR Berghofer scientists found the protein PD-L2 was overactive in people with Crohn’s disease. The study was led by the head of the Molecular Immunology group, Dr Michelle Wykes, and Dr Graham Radford-Smith, who leads the […]

Read more

Personal Story

Student with stoma accused of taking drugs

Posted: September 11 2019

Amber Davies, 21, from Builth Wells, has a stoma after being diagnosed with ulcerative colitis aged 13. While on a night out in Birmingham, she was “grabbed” by a bouncer after coming out of the disabled toilet. Wetherspoons said staff apologised for the “confusing situation”. Amber posted an open letter on her Instagram account detailing her experience, saying the […]

Read more

Research

Diet-induced remission of Crohn’s disease associated with altered microbial community structure

Researchers from the University of Pennsylvania looked at the association of diet, gut microbiome and IBD.

Background The microbiome has been implicated in the initiation and persistence of inflammatory bowel disease. Despite the fact that diet is one of the most potent modulators of microbiome composition and function and that dietary intervention is the first-line therapy for treating pediatric Crohn’s disease, the relationships between diet-induced remission, enteropathy, and microbiome are poorly […]

Read more

News

Serotonin and anti-depressants can have a major effect on the gut’s microbiota

Posted: September 11 2019

Serotonin — a neurotransmitter, or chemical messenger that sends messages among cells — serves many functions in the human body, including playing a role in emotions and happiness. An estimated 90% of the body’s serotonin is produced in the gut, where it influences gut immunity. The team — led by senior author Elaine Hsiao and […]

Read more